Method and apparatus for discovering target protein of targeted therapy

US2016378911A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016378911-A1
Application numberUS-201615196656-A
CountryUS
Kind codeA1
Filing dateJun 29, 2016
Priority dateJun 29, 2015
Publication dateDec 29, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An exemplary embodiment of the invention provides a discovery method of a protein which serves as a target of a target therapy, including: performing an attractor analysis on a first body signal transferring network of a cancer cell that is perturbed, and determining at least one of a plurality of proteins included in a third body signal transferring network of a cancer cell as a target protein based on the attractor analysis on the first body signal transferring network and an attractor analysis on a second body signal transferring network of a normal cell.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of discovering a protein which serves as a target of a target therapy, the method comprising: performing an attractor analysis on a first body signal transferring network of a perturbed cancer cell; and determining at least one of a plurality of proteins included in a third body signal transferring network of a cancer cell as a target protein based on the attractor analysis on the first body signal transferring network and an attractor analysis on a second body signal transferring network of a normal cell. 2 . The protein discovery method of claim 1 , wherein the performing the attractor analysis includes: modeling the third body signal transferring network by applying a mutation map of a cancer state to the second body signal transferring network; modeling the first body signal transferring network by perturbing at least one of the plurality of proteins included in the third body signal transferring network; and simulating a signal-transmitting operation of the first body signal transferring network by using a Boolean network model. 3 . The protein discovery method of claim 2 , wherein the modeling of the first body signal transferring network includes modeling the first body signal transferring network by perturbing a combination of some of the plurality of proteins included in the third body signal transferring network. 4 . The protein discovery method of claim 2 , wherein the simulating the signal-transmitting operation includes: determining the Boolean network model relating to a mutual relationship of proteins included in the first body signal transferring network; and time-dynamically simulating the first body signal transferring network based on the Boolean network model. 5 . The protein discovery method of claim 4 , wherein the simulating the signal-transmitting operation includes: generating a truth table relating to the mutual relationship of the proteins included in the first body signal transferring network based on the Boolean network model; generating a state transition table showing state transition of the proteins based on the truth table; and determining an attractor indicating a final state of each protein included in the first body signal transferring network by generating a state transition diagram based on the state transition table. 6 . The protein discovery method of claim 1 , wherein the simulating the signal-transmitting operation includes calculating a basin size of an attractor of the perturbed cancer cell based on the simulation result of the first body signal transferring network. 7 . The protein discovery method of claim 6 , wherein the determining at the least one of the plurality of proteins included in the third body signal transferring network of the cancer cell as the target protein includes: comparing a basin size of an abnormal one of attractors of the normal cell with a basin size of an abnormal one of attractors of the perturbed cancer cell; and, when a difference between the basin size of the abnormal one of the attractors of the normal cell with the basin size of the abnormal one of the attractors of the perturbed cancer cell is smaller than a predetermined value, determining at least one perturbed protein of the plurality of proteins included in the third body signal transferring network as the target protein. 8 . The protein discovery method of claim 6 , wherein the determining at the least one of the plurality of proteins included in the third body signal transferring network of the cancer cell as the target protein includes: comparing a first basin size ratio of normal attractors and abnormal attractors among attractors of the normal cell with a second basin size ratio of normal attractors and abnormal attractors among attractors of the perturbed cancer cell; and, when a difference between the first basin size ratio and the second basin size ratio is smaller than a predetermined value, determining at least one perturbed protein of the plurality of proteins included in the third body signal transferring network as the target protein. 9 . The protein discovery method of claim 7 , wherein the determining the at least one perturbed protein of the plurality of proteins included in the third body signal transferring network as the target protein further includes, when at least two of the proteins included in the third body signal transferring network are the target protein, determining at least one of combinations of the at least two proteins as the target protein. 10 . The protein discovery method of claim 9 , wherein the determining the at the least one of combinations of the at least two proteins as the target protein includes, when at least two of the proteins included in the third body signal transferring network are the target protein: generating a fourth body signal transferring network by making combinations of the at least two proteins and perturbing the combinations of the at least two proteins; and re-performing the attractor analysis on the fourth body signal transferring network. 11 . A discovery apparatus of a protein which serves as a target of a target therapy, the discovery apparatus comprising: at least one processor; a memory; and a transceiver, wherein the at least one processor executes at least one program stored in the memory to perform: performing an attractor analysis on a first body signal transferring network of a perturbed cancer cell; and determining at least one of a plurality of proteins included in a third body signal transferring network of a cancer cell as a target protein based on the attractor analysis on the first body signal transferring network and an attractor analysis on a second body signal transferring network of a normal cell. 12 . The protein discovery apparatus of claim 11 , wherein the at least one processor performs: modeling the third body signal transferring network by applying a mutation map of a cancer state to the second body signal transferring network; modeling the first body signal transferring network by perturbing at least one of the plurality of proteins included in the third body signal transferring network; and simulating a signal-transmitting operation of the first body signal transferring network by using a Boolean network model. 13 . The protein discovery apparatus of claim 12 , wherein the at least one processor, when performing the modeling of the first body signal transferring network, performs: modeling the first body signal transferring network by perturbing a combination of some of the plurality of proteins included in the third body signal transferring network. 14 . The protein discovery apparatus of claim 12 , wherein the at least one processor, when performing the simulating of the signal-transmitting operation, performs: determining the Boolean network model relating to a mutual relationship of the proteins included in the first body signal transferring network; and time-dynamically simulating the first body signal transferring network based on the Boolean network model. 15 . The protein discovery apparatus of claim 14 , wherein the at least one processor, when performing the time-dynamical simulating, performs: generating a truth table relating to the mutual relationship of the proteins included in the first body signal transferring network based on the Boolean network model; generating a state transition table showing state transition of the proteins based on the truth table; and determining an attractor indicating a final state of each protein included in the first body signal transferring netw

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016378911A1 cover?
An exemplary embodiment of the invention provides a discovery method of a protein which serves as a target of a target therapy, including: performing an attractor analysis on a first body signal transferring network of a cancer cell that is perturbed, and determining at least one of a plurality of proteins included in a third body signal transferring network of a cancer cell as a target protein…
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Korea Advanced Inst Sci & Tech
What technology area does this patent fall under?
Primary CPC classification G06F19/12. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).